Passive immunotherapy in advanced HIV infection and therapeutic plasmapheresis in asymptomatic HIV-positive individuals: A four-year clinical experience

Biotherapy

Volumn 11, Issue 1, 1998, Pages 7-14

  Blick, Gary ^a,b,c,d   Scott, William F ^a,b,c,d   Crook, Steven W ^a,b,c,d   Buchanan, Shari ^a,b,c,d   Garton, Trish ^a,b,c,d   Hopkins, Una ^a,b,c,d   Vadaboncoeur, Anne Marie ^a,b,c,d   Doolittle, James ^a,b,c,d   Bulcraig, Lain A ^a,b,c,d   Greiger Zanlungo, Paola ^a,b,c,d   Karpas, Abraham ^a,b,c,d  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Southern New England Community Consortium   (United States)

^c HERIOT WATT UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Passive immunotherapy in HIV disease and therapeutic plasmapheresis

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS-RELATED COMPLEX; BLOOD DONORS; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNIZATION, PASSIVE; MALE; MIDDLE AGED; PLASMAPHERESIS;

EID: 0031803332     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007920613598     Document Type: Article

References (16)

1. Bacchetti P, Moss AR. Incubation periods of AIDS in San Francisco.Nature 1989; 338: 251-253.
2. Cao Y, Qin L, Zhane L, Safrit J, Ho D. Virological and immunological characterisation of long term survivors of HIV-1-infection. NEJ Med 1995; 332: 201-208.
3. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emihi EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS and Shaw GM. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117-122.
4. Ho O, Neumann AU, Perelson AS, Chen W, Leonard JM and Markowitz M. Rapid turnover of plasma virus and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123-136.
5. Karpas A, Gilson W, Bevan PC, Gates JK. Lytic infection by British AIDS virus and the development of rapid cell test for antiviral antibodies. Lancet 1985; 695-697.
6. Karpas A, Hill F, Youle M, Cullen V, Gray J. Byron N, Hayhoe FGJ, Tenant-Flowers M, Howard L, Gilgen D, Oates J. Howkins D, Gazzard B. Effect of passive immunisation in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome. Proc Natl Acad Sei USA 1988; 85: 9234-9237.
7. Karpas A, Hewlett IK, Hill F, Gray J, Byron N, Gilgen D, Bally V, Oates JK, Gazzard B, Epstein JE. Polymerase chain reaction evidence for human immunodeficiency virus-1 neutralisation by passive immunisation in patients with AIDS and AIDSrelated complex. Proc Natl Acad Sei USA 1990; 87: 11951199.
8. Vittecoq D, Mattinger B, Barre-Sinoussi F, Couroucc AM, Rouzinoux C, Doinel C, Bary M, Viard JP, Bach JF, Ronger P, Lefrere JJ. Passive immunotherapy in AIDS: a randomised trial of serial human immunodeficieny virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. J Inf Diseases 1992; 165: 364-368.
9. Levy J, Youvan T, Lee ML. Passive hyperimmune therapy in the treatment of AIDS: Results of a multicentre double blind controlled trial. Blood 1994; 84: 2130-2135.
10. Vittecoq D, Chevret S, Morand-Joubert L, Heshamati F, Audit F, Bary M, Dusautoir J, Bismuth A, Viard JP, Barre-Sinousi F, Bach JF, Lefrere JJ. Passive immunotherapy in AIDS. A double blind randomized study based on transfusions of plasma rich in anti-human immunodeficieny virus 1 antibodies versus transfusions of seronegative plasma. Proc Natl Acad Sei 1995; 92: 1195-1199.
11. Concorde Co-ordinating Committee. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred Zidovudine in symptom-free HIV infection. Lancet 1994;343: 871-880.
12. Jacobson JM, Colman N, Ostrow NA, Simson RW, Tomesch D, Marlin L, Rao M. Mills JL. Clement J, Prince A. Passive immune therapy in treatment of advanced HIV infection. J Inf Dis 1993; 168: 288-305.
13. Hamilton JD, Hartigan PM, Simberkoff MS et al. A controlled trial of early versus late treatment with Zidovudine in symptomatic human immunodeficiency virus infection. New Engl J Med 1992; 326: 437-443.
14. Cummins LM, Weinhold KJ, Matthews TJ, Longlois AJ, Perno GF, Condie RM, Allain JP. Preparation and characterization of an intravenous solution IgG from HIV-seropositive donors. Blood 1991; 77: 1111-1117.
15. Stricker RB, Youvan TD, McGrath MF, Levy J. Potential benefit of repeated plasma donation in asymptomatic HIV-infecled individuals. Proceedings of the Sixteenth Annual Meeting of the American Society of Apheresis 1995; Abstract 88, p. 112.
16. Bainbridge D, Lowdell MW, Hármet IM, Strauss KW, Karpas A. Can repeated plasma donation by asymptomatic HIV-infected individuals delay the onset of AIDS? Philosophical Transactions: Royal Society Lond. B 1997; 352, 763-770.